Les détails du produit

loading

Partager sur:
facebook sharing button
twitter sharing button
line sharing button
wechat sharing button
linkedin sharing button
pinterest sharing button
sharethis sharing button

BioAerosol Monitoring System (2.83LPM) M120

BioAerosol Monitoring System (BAMS) is designed to meet exacting, pharmaceutical manufacturing standards while providing real-time data for immediate action and catastrophic loss avoidance.
 
 

Capacitive touch screen

Portable

8.0″

6.8Kg

Continuous monitoring

Mass storage

7*24hr

119G

 
État de disponibilité:

  • M120

         

       

PRODUCT FEATURES


               Continuous  

                  Real-time, continuous 

                  airborne microbial monitor


               Compliant 

                  ISO-21501 compliant particle counter

               Efficient

                  Efficient, 

                  user-oriented design


               Portable 

                  First truely portable microbial monitor

4cba9

Compliant with FDA 21 CFR Part 11




PRINCIPLE




Particle detecting: Mie scattering


5f221

Biological particle detecting: Laser induced flouresence



  

WAITING TIME vs REALTIME


 Current airborne microbial monitoring uses interval, ad-hoc and event-driven sample collection,

which requires incubation. BAMS uses AFU to count microbes, and the monitoring results 

can be viewed in real time without the need for culture or counting.


70faa


COMPENDIAL METHOD

  • 1-7 days

  • More scheduled/

    unscheduled breaks

  • Unlikely contamination

    identification


BAMS BENEFITS 

  • Immediate 

  • Likely contamination root cause identification

73e98


COMPENDIAL METHOD

  • Sampled monitoring 

  • Reduced accuracy 

  • Limited trending 

  • Greater contamination risk 

  • Greater risk of production loss


BAMS BENEFITS 

  • Continuous monitoring 

  • Trend data and improved analysis

  • Reduced contamination and production loss risks

76e89


COMPENDIAL METHOD

  • Resource intensive 

  • Time delays 

  • Higher labor costs


BAMS BENEFITS 

  • Minimal costs and resources 

  • lmmediate and online



SPECIFICATIONS


  • SIZE RANGE:  0.5µm - 25µm

  • LASER SOURCE:  Long life laser

  • COUNT EFFICIENCY:  50% ±20% for 0.5µm, 100% ±10% for >0.75µm (meets ISO 21501-4 and JIS B9921)

  • FLOW RATE:  2.83LPM±3%

  • ZONE / LOCATION:  20,000 rooms and 200,000 locations

  • SAMPLING MODE:  Manual, auto, beep, cumulative count Σ/ differential count Δ or concentration

  • CONCENTRATION LIMIT:  4,000,000 particles/ft³at 10% coincidence loss

  • EXHAUST:  Internal HEPA filter (>99.997%@0.3µm)

  • COMMUNICATION:  RJ45, USB, SENSER-HUB, WIFI (optional)

  • EXPORT FILE:  PDF file or EXCEL file

  • DATA STORAGE:  119G

  • DATA SECURITY:  Authority management, authority level divide into admin, operator and supervisor

  • ALARM:  Audible built-in alarm

  • DIMENSIONS (HxWxD):  10x7.87x10.39 in/255x200x264mm (with handle and foot mat)

  • WEIGHT:  14.9lbs/6.8Kg (with battery)

  • ENCLOSURE:  316L Stainless Steel and anodized aluminum

  • OPERATING CONDITIONS:  Temperature: 5°C -35° C / 41°F - 95°F, Relative humidity: 5-90% non-condensing

  • SAFETY:  EN 61010-1:2010+A1:2019, EN 61326-1:2013, EN 61326-2:2:2013, EN 60825-1:2014, EN 61000-6-1:2007, EN 61000-6-3:2007+A1, EN 62311:2008, EN 62479: 2010

  • Warranty: One year after activation







VIDEO


 

sur: 
En vertu d'un: 

modèle du produit

NOUS CONTACTER
Retour d'information
MicronView Limited tire parti de l'optique et de la biotechnologie pour atteindre une surveillance de l'environnement stérile rapide et en temps réel, en fournissant des instruments de surveillance avancés et en consommables pour les environnements de production et les produits finis des industries alimentaires, pharmaceutiques et cosmétiques.
Navigation Rapide

Catégorie de produits

MicronView Limited

1-520-528-1882
mv@micronview.com
2300 Highway 365 Suite 110, Pays-Bas Texas 77630, États-Unis
droits d'auteur 2021 Micron View Limited. Tous les droits sont réservés. Plancher| Soutenu par En avance